Result highlights include: Operating Cashflow Growth: Operating cashflow in the June-24 quarter surged by 666% compared to June-23, reaching $419K. Strong Financial Position: Closing cash balance as of 30 June 2024 stood at $2.066M, inclusive of $596K in Convertible Notes. Successful Implementation of MasterCare: MasterCare...
Placement of Convertible Notes, raising up to $1,000,000 before costs; Funds raised to provide a buffer to available cash in the event the challenging business conditions impacting on hospital clients worsen; The Company’s directors have each subscribed for $50,000 (subject to shareholder approval). Global Health...
Result highlights include: Year To Date (YTD) Revenue to March up 12% on the Previous Corresponding Period (PCP) Operating Cashflow improves by 69% from the PCP Group Cashflow improves by 61% from the PCP Global Health Limited (ASX: GLH) (“Global Health” or “the Group”) is pleased...
Result highlights include: Revenue up 27% or $856K to $4.039M Expenses reduced by 12% or $0.69M to ($5.2M) EBITDA up 58% or $1.5M to ($1M) Innovation investments (R&D) increase 84% to $1.468M Global Health Limited (ASX: GLH) (“Global Health” or “the Group”) is pleased to release...